Shionogi and Osaka University unveils a new joint research lab to review anti-COVID-19 drug

Shionogi & Co., Ltd. and Osaka University have established a joint research laboratory (research lab’s name: J...

March 1, 2024 | Friday | News
"One example of success is the development of a potential new paediatric treatment for schistosomiasis"

Could you give us an overview of the GHIT Fund's mission and how it originated? The idea for the GHIT (Global Health In...

March 1, 2024 | Friday | Opinion
Japan's Otsuka Pharma enters into $30 M investment contract with AN Venture Partners

Japan headquartered Otsuka Pharmaceutical Co. has concluded an investment contract of $30 million with AN Venture Part...

March 1, 2024 | Friday | News
Japan's Daiichi Sankyo invests €1B in Germany site, expanding into innovation centre

With investments of approximately one billion euros, Japan headquartered Daiichi Sankyo will expand its production and ...

February 29, 2024 | Thursday | News
Japan's Takeda accelerates dengue vaccine access through manufacturing partnership with Biological E in India

Japanese pharmaceutical company Takeda has announced a strategic partnership with Biological E, a le...

February 27, 2024 | Tuesday | News
Japan's Nanophoton strengthens Bruker’s portfolio of molecular microscopy research solutions

US-based Bruker Corporation has announced the acquisition of Nanophoton Corporation, a pioneer focused on...

February 19, 2024 | Monday | News
Japan's Astellas Pharma inks oncology deal worth $800 M with US-based biotech startup Kelonia

Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...

February 20, 2024 | Tuesday | News
Japan first in world to approve Dupixent for chronic spontaneous urticaria

The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted marketing and manufacturing authorisation for Dup...

February 16, 2024 | Friday | News
US Centers for Disease Control and Prevention opens new East Asia and Pacific office in Tokyo

US Centers for Disease Control and Prevention (CDC) Director Mandy Cohen has announced the opening of the new C...

February 16, 2024 | Friday | News
Japan approves Metoject Methotrexate Autoinjector pen for rheumatoid arthritis

Japan has approved manufacturing and marketing authorisation for the Metoject Subcutaneous Injection Pen (Methotrex...

February 16, 2024 | Friday | News
Korea's STARmed accelerates global market entry of medtech products through Olympus in Japan

STARmed, a South Korea-based medical device manufacturer specialising in thermal ablation technology, has announced glob...

February 15, 2024 | Thursday | News
Takeda, Dundee and Cambridge reunite in fight against dementia

UK-based University of Dundee’s Drug Discovery Unit has announced a renewed partnership with Japanese pharmaceut...

February 14, 2024 | Wednesday | News
Japan's Shimadzu announces development of new technology to improve healthy life expectancy

Japan-based Shimadzu Corporation and Shimadzu Scientific Instruments (SSI) have announced the development of an innovati...

February 13, 2024 | Tuesday | News
Sysmex and Hitachi High-Tech to collaboratively develop New Genetic Testing Systems

Sysmex Corporation and Hitachi High-Tech Corporation are collaborating to develop novel genetic testing systems based on...

February 8, 2024 | Thursday | News
ZimVie launches Next-Generation TSX® dental Implant in Japan

ZimVie Inc., a global life sciences leader in the dental and spine markets, has launched TSX® Implant in Japan....

February 8, 2024 | Thursday | News
BridgeBio Pharma and Kyowa Kirin ink $100 M deal for skeletal dysplasias treatment in Japan

BridgeBio Pharma, Inc. and Kyowa Kirin have announced a partnership wherein BridgeBio’s affiliate, QED Therapeutic...

February 12, 2024 | Monday | News
Japan's Chugai to position Singapore subsidiary as permanent global drug discovery research centre

Chugai Pharmaceutical has decided to position its research subsidiary in Singapore, Chugai Pharmabody Research...

February 5, 2024 | Monday | News
Japan's Takeda Pharma inks haematology deal worth $300 M with US-based Protagonist Therapeutics

Japan-based pharmaceutical firm Takeda and US-based Protagonist Therapeutics have inked a global license and collaborati...

February 2, 2024 | Friday | News